No benefit of olaparib in previously untreated, platinum-ineligible, metastatic urothelial carcinoma Presented ByDr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center, NY, USA TrialPhase 2, BAYOU ConferenceASCO GU 2022 8 April, 2022 11:19